A detailed history of Principal Financial Group Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 14,260 shares of NKTX stock, worth $75,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,260
Previous 15,793 9.71%
Holding current value
$75,007
Previous $104,000 48.08%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$5.59 - $15.71 $8,569 - $24,083
-1,533 Reduced 9.71%
14,260 $154,000
Q4 2023

Feb 07, 2024

BUY
$1.31 - $6.6 $1,687 - $8,500
1,288 Added 8.88%
15,793 $104,000
Q2 2023

Aug 07, 2023

BUY
$2.19 - $5.17 $7,923 - $18,705
3,618 Added 33.23%
14,505 $31,000
Q1 2023

May 09, 2023

BUY
$3.37 - $6.3 $2,389 - $4,466
709 Added 6.97%
10,887 $38,000
Q4 2022

Feb 09, 2023

BUY
$5.14 - $14.35 $52,314 - $146,054
10,178 New
10,178 $60,000
Q3 2021

Nov 09, 2021

SELL
$26.67 - $38.76 $200,691 - $291,669
-7,525 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$23.94 - $36.68 $180,148 - $276,017
7,525 New
7,525 $238,000
Q1 2021

May 10, 2021

SELL
$31.33 - $59.61 $111,252 - $211,675
-3,551 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$27.03 - $75.62 $95,983 - $268,526
3,551 New
3,551 $218,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $256M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.